Sonoma Bio named as one of most promising startups in biotech by Endpoints News
Thank you, for naming Sonoma Biotherapeutics an Endpoints 11 company. And congratulations to the Sonoma employees, investors and partners who have helped us find success at this early juncture along our journey.